ResMedMEX:RMD 99 Median PS Value is MXN5,272.21 as of Jun. 24, 2026, which is 100% below its 10-year median of 1.28. GuruFocus rates MEX:RMD with a GF Score™ of 99/100 and a GF Value™ of MXN5,298.64 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 337 Medical Devices & Instruments companies, ResMed ranks worse than 50.15% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. ResMed's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was MXN691.527. ResMed's 10-Year median PS Ratio is 7.624. Therefore, the Median PS Value for today is MXN5,272.21.
As of today (2026-06-24), ResMed's share price is MXN3716.10. ResMed's Median PS Value is MXN5,272.21. Therefore, ResMed's Price to Median PS Value for today is 0.70.
The historical rank and industry rank for ResMed's Median PS Value or its related term are showing as below:
MEX:RMD'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.7 Med: 1.28 Max: 2.22
Current: 0.7
During the past 13 years, the highest Price to Median PS Value of ResMed was 2.22. The lowest was 0.70. And the median was 1.28.
MEX:RMD's Price-to-Median-PS-Value is ranked worse than 50.15% of 337
companies
in the Medical Devices & Instruments industry
Industry Median: 0.7
vs MEX:RMD: 0.70
ResMed (MEX:RMD) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
ResMed's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
3716.10
/
5,272.21
=
0.70
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ResMed Median PS Value Related Terms
ResMed Median PS Value Historical Data
* Premium members only.
The historical data trend for ResMed's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:RMD vs MDLN, WST, BDX: Median PS Value Comparison
For the Medical Instruments & Supplies subindustry, ResMed's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ResMed Price-to-Median-PS-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ResMed's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where ResMed's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 7.624.
ResMed's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN691.527.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ResMed (MEX:RMD) has a Median PS Value of MXN5,272.21 as of Jun. 24, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on ResMed and its competitors. This is 411791% above median its historical median of 1.28. Over the past decade, ResMed's Median PS Value has ranged from 0.70 to 2.22. According to the industry distribution chart, ResMed ranks #169 out of 337 companies in the Medical Devices & Instruments industry, placing it in the top 50.1%.
Is ResMed's Median PS Value too high?
ResMed's current Median PS Value of MXN5,272.21 is 411791% above median its 10-year median of 1.28. Over the past 10 years, this metric has ranged from a low of 0.70 to a high of 2.22. Based on the distribution chart, ResMed ranks #169 out of 337 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, ResMed has a GF Score™ of 99/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ResMed's Median PS Value compare to MDLN and WST?
According to the Medical Devices & Instruments industry distribution chart, ResMed ranks #169 out of 337 companies for Median PS Value. This places ResMed in the lower half of its industry. The industry median Median PS Value is 0.70. Historically, ResMed's own Median PS Value has ranged from 0.70 to 2.22 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Devices & Instruments company?
The median Median PS Value among Medical Devices & Instruments companies is 0.70, based on 337 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on ResMed and its competitors. For the Medical Devices & Instruments industry, the median Median PS Value is 0.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ResMed's current Median PS Value is MXN5,272.21, which is 411791% above median its own 10-year median of 1.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ResMed stock overvalued right now?
Based on GuruFocus' analysis, ResMed (MEX:RMD) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN5,298.64, compared to a current price of MXN3,716.10 — trading 29.9% below its estimated fair value. The current Median PS Value is MXN5,272.21, which is 411791% above median its 10-year median of 1.28. ResMed's overall GF Score™ is 99/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For ResMed (MEX:RMD), the current Median PS Value is MXN5,272.21 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ResMed (MEX:RMD) Overvalued in 2026?
Based on GuruFocus' analysis, ResMed stock appears to be undervalued.
The current stock price of MXN3,716.10 is trading 29.9% below its estimated GF Value™ of MXN5,298.64.
GuruFocus considers ResMed to be Significantly Undervalued.
Key valuation signals for MEX:RMD:
Median PS Value: MXN5,272.21 (411791% above median its 10-year median of 1.28)
GF Value™: MXN5,298.64 vs. price of MXN3,716.10 (29.9% below fair value)
No single metric tells the full story. See the MEX:RMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with aging populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.
99GF Score
Get the complete analysis for MEX:RMD
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:RMD has been successfully added to your 
